Literature DB >> 8291509

Chenodeoxycholate: the bile acid. The drug. a review.

G Broughton1.   

Abstract

Chenodeoxycholate (3 alpha, 7 alpha-dihydroxy-5 beta-cholanic acid) is a primary bile acid directly synthesized from cholesterol. It is an amphipathic molecule, possessing both a hydrophobic side and a polar hydrophilic side, giving it the ability to solubilize lipids in a water environment. Bile acids are necessary for the absorption of fats and fat soluble vitamins. Chenodeoxycholate inhibits the rate-limiting step of cholesterol synthesis, the formation of hydroxymethyl-glutaryl-coenzyme A. It was first reported to be useful in the dissolution of cholesterol gallstones in 1972. Today, chenodeoxycholate has other medicinal uses and is used for the management of cerebrotendinous xanthomatosis, hypertriglyceremia, congenital liver diseases, rheumatoid arthritis, and constipation. This article details some finer points of chenodeoxycholate biochemistry and physiology and discusses in some detail the current and past clinical uses of chenodeoxycholate. This is not an exhaustive discussion on gallstone dissolution therapies, but an overview of some of the lesser-known uses for this drug.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8291509     DOI: 10.1097/00000441-199401000-00011

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  6 in total

1.  Expression and activation of the farnesoid X receptor in the vasculature.

Authors:  David Bishop-Bailey; Desmond T Walsh; Timothy D Warner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

2.  Effects of Fat Type and Exogenous Bile Acids on Growth Performance, Nutrient Digestibility, Lipid Metabolism and Breast Muscle Fatty Acid Composition in Broiler Chickens.

Authors:  Shixia Geng; Yuxin Zhang; Aizhi Cao; Ying Liu; Yuting Di; Juntao Li; Qianqian Lou; Liying Zhang
Journal:  Animals (Basel)       Date:  2022-05-13       Impact factor: 3.231

3.  Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate, in healthy and diabetic rats.

Authors:  M Mikov; N S Boni; H Al-Salami; K Kuhajda; S Kevresan; S Golocorbin-Kon; J P Fawcett
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jan-Mar       Impact factor: 2.441

4.  Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice.

Authors:  Diana M Shih; Zory Shaposhnik; Yonghong Meng; Melenie Rosales; Xuping Wang; Judy Wu; Boris Ratiner; Filiberto Zadini; Giorgio Zadini; Aldons J Lusis
Journal:  FASEB J       Date:  2013-06-10       Impact factor: 5.191

5.  Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis.

Authors:  Zhao-wei Yan; Ji Dong; Chen-hao Qin; Chun-yang Zhao; Li-yan Miao; Chun-yan He
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

Review 6.  Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions.

Authors:  Melissa Jones; Corina Mihaela Ionescu; Daniel Walker; Susbin Raj Wagle; Bozica Kovacevic; Jacqueline Chester; Thomas Foster; Edan Johnston; Jafri Kuthubutheen; Daniel Brown; Marcus D Atlas; Momir Mikov; Armin Mooranian; Hani Al-Salami
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.